Mind Medicine (MindMed) Inc (MNMD) is higher by 6.99% Wednesday In Premarket Trading

Mind Medicine (MindMed) Inc (MNMD) has risen Wednesday morning, with the stock adding 6.99% in pre-market trading to 3.06. MNMD's short-term technical score of 22 indicates that the stock has traded less bullishly over the last month than 78% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, Mind Medicine (MindMed) Inc ranks higher than 27% of stocks. Mind Medicine (MindMed) Inc has fallen 1.04% over the past month, closing at $2.82 on October 19. During this period of time, the stock fell as low as $2.41 and as high as $3.12. MNMD has an average analyst recommendation of Strong Buy. The company has an average price target of $42.25.

MNMD has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on MNMD!

See Full MNMD Report

Mind Medicine (MindMed) Inc has a Long-Term Technical rank of 33. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 67% of the market scoring higher. In the Biotechnology industry which is number 117 by this metric, MNMD ranks better than 117% of stocks.

Important Dates for Investors in MNMD:

-Mind Medicine (MindMed) Inc is set to release earnings on 2/8/2023. Over the last 12 months, the company has reported EPS of $-0.03. -We do not have a set dividend date for Mind Medicine (MindMed) Inc at this time. Click Here To Get The Full Report on Mind Medicine (MindMed) Inc (MNMD)